# Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

> **NCT06864936** · NA · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Sclerosis (MS) - Relapsing-remitting

## Interventions

- **DRUG:** Ublituximab
- **OTHER:** Other disease modifying therapies

## Key facts

- **NCT ID:** NCT06864936
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-01-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06864936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06864936, "Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06864936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*